Navigation Links
DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
Date:1/30/2013

Dallas, TX (PRWEB) January 30, 2013

The patient advocates at DrugRisk.com are alerting those taking the blood thinner Pradaxa of new information added to the site which shows the judge presiding over the ongoing internal bleeding lawsuits has ordered the drug maker to disclose information on prior fraud charges.

The goal of DrugRisk is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. “In many cases, patients follow litigation to learn more about a drug they’re taking and what questions to ask their doctor,” explains DrugRisk representative Ryan Mayer.

The resource center previously added a report from the Institute for Safe Medication Practices which ranked anticoagulants like Pradaxa among the highest risk outpatient drugs. The Institute also found that hemorrhage cases submitted to the FDA show bleeding from Pradaxa was nearly 5 times as likely to result in death than with warfarin.*

Reports show that experts still disagree about the safety of Pradaxa and its bleeding risks. While there has been no official Pradaxa recall, the FDA recently issued an update that the drug carries the same risks as warfarin.** However, the Americal College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.***

DrugRisk has learned that, due to the number of patients filing a Pradaxa lawsuit, they are being consolidated in a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, the resource center has learned that, Judge Herndon, who is overseeing the Pradaxa litigation, signed an order on January 19th denying attempts by Pradaxa maker Boehringer Ingelheim to protect information on prior lawsuits regarding false promotion, marketing or kickbacks for their drugs.****

Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Instutute for Safe Medication Practices, 1/9/13; http://ismp.org/quarterwatch/pdfs/2012Q2.pdf
** http://fda.gov/Drugs/DrugSafety/ucm326580.htm
*** http://content.onlinejacc.org/article.aspx?articleid=1206384
**** http://www.ilsd.uscourts.gov/opinions/ilsd_live.3.12.md.2385.2251290.0.pdf#search=%22pradaxa%22

Read the full story at http://www.prweb.com/releases/pradaxa-litigation/pradaxa-recalled/prweb10355992.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
2. DrugRisk Announces New Pradaxa Health Warning From Australia
3. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
4. DrugRisk Announces Updated Information on Mirena Lawsuits
5. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
6. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
7. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
8. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
9. HRT Update: Therapy May Reduce Fractures, Boost Some Risks
10. New Transvaginal Mesh Lawsuit in American Medical Systems Pelvic Mesh Litigation filed by Wright & Schulte LLP is Underway in West Virginia Federal Court
11. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... ... Business Journalists , led by the Wharton School’s most prominent professors, help ... one-day program at the Wharton School’s San Francisco campus will feature Wharton ...
(Date:5/5/2016)... ... 05, 2016 , ... Derrin Doty Group has unveiled the latest charity campaign ... communities west of Seattle. The insurance provider’s caring team has been so moved by ... due to complications from the flu, that they have decided to extend their original ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... commencement of a master charity program created to assist the people of their ... working closely with nonprofit organizations and community leaders. Their hope is to bring ...
(Date:5/5/2016)... ... May 05, 2016 , ... Long Island’s fastest growing comprehensive eye care ... Island eye surgeon, Kathleen Van Valkenburg, MD as part of their ongoing effort to ... medical director and managing partner of North Shore Eye Care. , “We are ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... Pittsburgh-area schoolchildren has found that more than 40 percent of participating fifth-grade students ... , Director of Allergy and Asthma Clinical Research in the Division of Pulmonary, ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 5, 2016 ... addition of the  "Europe Systemic Lupus Erythematosus ...  report to their offering.       ... The latest research Europe Systemic Lupus Erythematosus ... provides comprehensive insights into Systemic Lupus Erythematosus ...
(Date:5/4/2016)... an upgrade. There are many medical recorders on the market but none like this. ... HD  offers unparalleled connectivity and functionality.  Ampronix  is a renowned authorized reseller of the ... Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... JERUSALEM , May 4, 2016 ... University of Jerusalem announced today that it had ... BioTheryX, Inc. , developer of novel protein degradation ... the development and commercialization of drug candidates representing first-in-class ... the license were not disclosed. The novel ...
Breaking Medicine Technology: